The UvAcare project: intervention - Examining the effectiveness of a web-based intervention for symptoms of depression and/or anxiety in university and PhD students.

The UvAcare project: intervention - Examining the effectiveness of a web-based intervention for symptoms of depression and/or anxiety in university and PhD students. - The UvAcare project - Intervention

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON48683

Enrollment

1100

Registered

2018-08-24

Start date

2019-01-25

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychische stoornissen: angststoornissen en -symptomen anxiety mood disorder

Interventions

The intervention will be a guided or unguided web-based transdiagnostic intervention targeting symptoms of depression and/ or anxiety. The intervention consists of 7 online sessions with duration ra

Eligibility

Age

12 Years to 99 Years

Inclusion criteria

Inclusion criteria: (a) Being enrolled as a student or PhD student at the University of Amsterdam (UvA) (b) Being 16 years or older (c) Students who experience symptoms of depression (as defined by a score within the range of 15 to 60 points on the Center for Epidemiological Studies Depression Scale [CES-D]) and/or anxiety (as defined by scoring above the cut-off score of 4 on the Generalised Anxiety Disorder scale - 7 items [GAD-7]).

Exclusion criteria

Exclusion criteria: (a) Co-morbid bipolar disorder and/or psychotic disorder according to the MINI (b) Currently receiving psychological treatment for depression and/or anxiety (c) Having slow or no Internet connection (e.g. no broadband Internet or something comparable) (d) No informed consent before participation

Design outcomes

Primary

Measure	Time frame
The primary outcome of the RCT are the PHQ-9 for self-reported symptoms of depression and the GAD-7 for self-reported symptoms of anxiety. These scales will be administered at pre-treatment, mid-intervention (5 weeks post-randomisation), 8 weeks post-randomisation and at 6 and 12 month follow-up measurements.	—

Secondary

Measure	Time frame
The secundary outcomes are the EQ-5D for quality of life, the Audit-C for alcohol use, the SIAS-6 (social interaction anxiety), the DAST-10 for drug use, the ASM for avoidance support and the Mini-SPIN for social anxiety. In addition, the Client Satisfaction Questionnaire - 8 items (CSQ-8) and medical service consumption (TiC-P) will be monitored. Finally, academic achievement, social isolation, loneliness, cognitive interpretation bias, perfectionism, attachment and burn-out are assessed with self-report measures.	—

Measure

Time frame

The secundary outcomes are the EQ-5D for quality of life, the Audit-C for alcohol use, the SIAS-6 (social interaction anxiety), the DAST-10 for drug use, the ASM for avoidance support and the Mini-SPIN for social anxiety. In addition, the Client Satisfaction Questionnaire - 8 items (CSQ-8) and medical service consumption (TiC-P) will be monitored. Finally, academic achievement, social isolation, loneliness, cognitive interpretation bias, perfectionism, attachment and burn-out are assessed with self-report measures.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)